Back to Journals » OncoTargets and Therapy » Volume 11

CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer

Total article views   HTML views PDF downloads Totals
9,524 Dovepress* 8,012+ 1,052 9,064
PubMed Central* 1,512 387 1,899
Totals 9,524 1,439 10,963
*Since 6 September 2018

View citations on PubMed Central and Google Scholar